Relationship between apolipoprotein E polymorphism, menopausal symptoms, and serum lipids during hormone replacement therapy

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 79, Issue 2, 1998, Pages 185-191

  Somekawa, Yoshiaki ^a   Wakabayashi, Akira ^a  

^a Toride Kyodo General Hospital   (Japan)

Author keywords

Apolipoprotein E polymorphism; Body fat masses; Climacteric symptoms; Hormone replacement therapy; Lipid; Lipoprotein

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN E; APOLIPOPROTEIN E4; CHOLESTEROL; ESTROGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEDROXYPROGESTERONE ACETATE;

ADULT; ARTICLE; ATHEROSCLEROSIS; FEMALE; GENETIC POLYMORPHISM; HORMONE SUBSTITUTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID ANALYSIS; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MENOPAUSE; PHENOTYPE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS;

EID: 0032144541     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(98)00008-6     Document Type: Article

References (23)

1. Boyles J.K., Zoellner C.D., Anderson L.J.et al. A role for apolipoprotein A-I and low density lipoprotein receptor in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J Clin Invest. 83:1989;1015-1031.
2. Saunders A.M., Strittmatter W.J., Schmechel D.et al. Association of apolipoprotein E allele ε4 with late onset familial and sporadic Alzheimer's disease. Neurology. 43:1993;1467-1472.
3. Saunders A.M., Schmader K., Breitner J.C.et al. Apolipoprotein E ε4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet. 342:1993;710-711.
4. Henderson A.S., Easteal S., Jorm A.F.et al. Apolipoprotein E allele ε4, dementia and cognitive decline in a population sample. Lancet. 346:1995;1387-1390.
5. Lehtinen S., Lehtimaki T., Sisto T.et al. Apolipoprotein E polymorphism, serum lipids, myocardial infarction and severity of angiographically verified coronary artery disease in men and women. Atherosclerosis. 114:1995;83-91.
6. Zung W.W.K., Richards C.B., Short M.J. Self-Rating Depression Scale in an outpatient clinic. Arch Gen Psychiatry. 13:1965;508-515.
7. Kataoka S., Paidi M., Howard V. Simplified isoelectric focusing/immunoblotting determination of apolipoprotein E phenotype. Clin Chem. 40:1994;11-13.
8. Nauck M., Marz W., Haas B., Wieland H. Homogeneous assay for direct determination of high-density lipoprotein cholesterol evaluated. Clin Chem. 42:1996;424-429.
9. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem. 18:1972;499-502.
10. Kushner R.F., Scholler D.A. Estimation of total body water by bioelectorical impedance analysis. Am J Clin Nutr. 44:1986;417-424.
11. Schmidt R., Schmidt H., Fazekas F.et al. Apolipoprotein E polymorphism and silent microangiopathy-related cerebral damage. Stroke. 28:1997;951-956.
12. Asada T., Yamagata Z., Kinoshita T.et al. Prevalence of dementia and distribution of apo E alleles in Japanese centenarians: An almost-complete survey in Yamanashi prefecture, Japan. J Am Geriatr Soc. 44:1996;151-155.
13. Al-Chalabi A., Enayat Z.E., Balkier M.C.et al. Association of apolipoprotein E ε4 allele with bulbar-onset motor neuron disease. Lancet. 347:1996;159-160.
14. Adlercreutz H., Hamalainen E., Gorbach S., Goldin B. Dietary phytoestrogens and the menopause in Japan. Lancet. 339:1992;1233.
15. Zhang S.H., Reddick R.H., Piedrahita J.A., Maeda N. Spontaneous hypercholesterolemia and arterial lesion in mice lacking apolipoprotein E. Science. 258:1992;468-471.
16. Mahley R.W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 240:1988;622-630.
17. Havel R.J., Yamada N., Shames D.M. Role of apolipoprotein E in lipoprotein metabolism. Am Heart J. 113:1987;470-474.
18. Windler E., Kovanen P.T., Chao Y.S., Brown M.S., Havel R.J., Goldstein J.L. The estradiol-stimulated lipoprotein receptor of rat liver. J Biol Chem. 255:1980;10464-10471.
19. Huang Y., Von Eckardstein A., Wu S., Assmann G. Effects of the apolipoprotein E polymorphism on uptake and transfer of cell-derived cholesterol in plasma. J Clin Invest. 96:1995;2693-2701.
20. Karas R.H., Patterson B.L., Mendelsohn M.E. Human vascular smooth muscle cells contain functional estrogen receptor. Circulation. 89:1994;1943-1950.
21. Saure A., Hirvonen E., Tikkanen M.J., Viinikka L., Ylikorkala O. A novel oestrdiol-desogestrel preparation for hormone replacement therapy: Effects hormones, lipids, bone, climacteric symptoms and endometrium. Maturitus. 16:1993;1-12.
22. Brain W.W., Isaac S., Bernard R., Louise G., Veroniga R., Frank M. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. New Engl J Med. 325:1991;1196-1204.
23. Crook D., Cust M.P., Gangar K.F.et al. Comparison of transdermal and or estrogen/progestin hormone replacement therapy. Am J Obstet Gynecol. 166:1992;950-955.